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 63 
Abstract 64 
Fever is one of the most common reasons for healthcare seeking globally and the majority of 65 
human pathogens are zoonotic. We conducted a systematic review to describe the occurrence 66 
and distribution of zoonotic causes of human febrile illness reported in malaria endemic 67 
countries. Articles included in the review yielded data from 53 (48·2%) of 110 malaria 68 
endemic countries. The 244 articles included described diagnosis of 30 zoonoses in febrile 69 
people. The majority of zoonoses were bacterial (n=17), with viruses (n=9), protozoa (n=3) 70 
and helminths (n=1) also identified. Leptospira spp. and nontyphoidal Salmonella serovars 71 
were the most frequently reported pathogens. Despite evidence of profound data gaps, this 72 
review reveals widespread distribution of a diverse range of zoonotic causes of febrile illness. 73 
Greater understanding of the epidemiology of zoonoses in different settings is needed to 74 
improve awareness and management of the multiple zoonotic causes of febrile illness. 75 
 76 
Introduction 77 
Fever is one of the most common symptoms prompting healthcare seeking globally.1-3 Fever 78 
has myriad causes and their non-specific clinical presentation means that clinical history and 79 
physical examination are often insufficient to accurately identify causal pathogens.1 80 
Limitations in laboratory services and available diagnostic tools further contribute to 81 
diagnostic challenges.4 In malaria-endemic countries, fever is often assumed to be due to 82 
malaria.5 The mortality and morbidity attributable to malaria remains considerable, but there 83 
is also evidence of widespread over-diagnosis within malaria-endemic areas.6-8 The 84 
recognized over-diagnosis of malaria together with declines in malaria incidence since the 85 
peak in global malaria deaths in 20049,10 have prompted attention to non-malaria causes of 86 
fever in malaria-endemic areas.11,12 Zoonotic pathogens are likely to play a substantial role as 87 
causes of fever globally. Almost two-thirds of all human pathogens are zoonotic,13 and there 88 
is growing evidence that many zoonoses cause more cases of human febrile illness than 89 
previously appreciated.12,14-20 Improved understanding of the impacts and burdens of zoonotic 90 
causes of fever in malaria-endemic countries would provide the epidemiological evidence 91 
base for disease control program development and also influence diagnostic and treatment 92 
algorithms for fever, with the potential to improve clinical outcomes. The aim of this study 93 
was to systematically review the published literature to describe the occurrence and 94 




Search strategy and selection criteria 99 
The target literature for this systematic review was peer-reviewed published articles that 100 
described the testing of one or more febrile person from malaria-endemic countries for one or 101 
more zoonotic pathogen using robust diagnostic testing criteria to demonstrate acute 102 
infection. Literature searches of the Medline and Embase databases were run using the 103 
OvidSP gateway. Searches were limited to English language articles published in the period 104 
2004 to 2019 inclusive, to span the period from the described peak of global malaria 105 
mortality in 2004 to present.9 The searches were last executed on 03 January 2019. Outputs 106 
of database searches were combined and de-duplicated using R.21 Additional details of 107 
searches, screening, review, and data extraction processes are given in the appendix. 108 
 109 
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Three search concepts for ‘fever,’ ‘zoonoses,’ and ‘malaria endemic countries’ were 110 
constructed. To construct the ‘fever’ concept the exploded subject heading and keywords 111 
were combined using database appropriate syntax (e.g., exp Fever/ OR fever$1.mp. OR 112 
febrile.mp.). For the ‘zoonoses’ concept, a reference list of eligible zoonotic pathogens was 113 
compiled using lists of zoonotic diseases from the World Health Organization (WHO)22 and 114 
World Organisation of Animal Health (OIE)23 as well as literature-based searches to identify 115 
frequently reported zoonotic causes of human fever. We conducted preliminary searches of 116 
Medline and Embase using the search syntax ‘(exp Fever/ OR fever.mp.) AND (exp 117 
Zoonoses/ OR zoonoses.mp OR zoonosis.mp)’ limited to humans. Additional details of 118 
search concept construction are given in the appendix. All pathogens identified through these 119 
approaches were mapped to existing subject headings and keywords at the lowest taxonomic 120 
level possible, typically genus or species. In instances where pathogen species or serovars 121 
within the same genus varied in their zoonotic status, search concepts were constructed to 122 
include all zoonotic and non-zoonotic species or serovars and articles relating to non-123 
zoonotic species were excluded at the full text stage. The candidate pathogens were classified 124 
to differentiate pathogens normatively acquired by people through direct or indirect 125 
transmission from vertebrate animals to humans, as compared to pathogens where zoonotic 126 
transmission has been recorded but where the majority of human infections are not acquired 127 
through zoonotic transmission. We classified pathogens using the stages in the process 128 
towards human endemicity defined in Wolfe et al.24 Pathogens classified at stages one to 129 
three (normatively acquired through zoonotic transmission) were retained (appendix). The 130 
search concept for each pathogen or disease included exploded subject headings for both the 131 
pathogen and the diseases caused in humans and terms for both pathogen and disease were 132 
also included as keywords (e.g., exp anthrax/ OR anthrax.mp. OR exp Bacillus anthracis/ OR 133 
bacillus anthracis.mp.). The list of pathogen or disease specific searches was combined using 134 
OR syntax to generate the full ‘zoonoses’ search concept (appendix). The ‘malaria endemic 135 
countries’ concept was constructed by mapping country names for countries defined as 136 
malaria endemic in the WHO global malaria reports for the years 2005 and 2016 to Medline 137 
and Embase subject headings.10,25 Each country was searched for using both the exploded 138 
subject heading where possible and keywords in all cases (e.g., exp Kenya/OR Kenya.mp.). 139 
The three concepts, fever,’ ‘zoonoses,’ and ‘malaria endemic countries’ were combined using 140 
AND operators and database specific syntax (appendix). 141 
 142 
Study selection and validity assessment 143 
Articles that reported the diagnosis of a zoonotic pathogen in a population from a malaria 144 
endemic country defined on the basis of febrile illness were selected for full-text review. 145 
Conference proceedings and records that did not include any abstract text or an abstract in 146 
English were excluded. Abstracts and titles were screened by two independent reviewers (two 147 
of MC, MES, KJA, GAFL, DVH, JAC, SC and MPR) using pre-defined criteria (appendix 148 
table S1). Articles were selected for inclusion if the abstract or title described clinical and/or 149 
laboratory evaluation of a group of ≥ 2 people all of whom had fever and some of whom 150 
were diagnosed of one or more pathogens from the reference list of zoonotic pathogens (table 151 
1). Abstracts referring to the use of blood culture were also retained at this stage even if a 152 
zoonosis was not explicitly mentioned in the abstract (appendix table S1). When two 153 
reviewers disagreed on article classification, a third independent reviewer (one of JEBH, MC, 154 
MES, GAFL, DVH or MPR) resolved the tiebreak. Full text articles were sought for all 155 
articles not excluded during abstract review steps. All articles were searched for using 156 
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PubMed, Google and the libraries of the University of Glasgow, Duke University, 157 
Washington University in St. Louis, and US Centers for Disease Control and Prevention (US 158 
CDC). Articles were excluded if a full text for the citation could not be obtained. Two 159 
independent reviewers (two of, JEBH, MC, MES, JB and MPR) evaluated full text articles 160 
using pre-defined inclusion and exclusion criteria (table 2, appendix table S2). Strict 161 
diagnostic case definitions based on WHO and US CDC guidelines ensured that only studies 162 
reporting robust and specific diagnostic methods were retained (table 2). Articles were 163 
excluded if they did not meet one or more of the study inclusion criteria or if they did meet at 164 
least one of the study exclusion criteria (table 2). In cases where reviewers disagreed on 165 
article classification, discrepancies were checked and resolved by JEBH in discussion with 166 
other reviewers.  167 
 168 
Table 1. Zoonoses included in the review, with details of species and serovars excluded 169 
where appropriate.  170 
Pathogen Species, subspecies, and serovars excluded Pathogen 
type13  
Alphaviruses All species excluded with the exception of Eastern 
equine encephalitis virus (EEEV) complex, 
Venezuelan equine encephalitis (VEEV) complex, 
and Western equine encephalitis (WEEV) complex 
Virus 
Anaplasma spp. - Bacteria 
Aphthoviruses All species excluded with the exception of Foot-and-
mouth disease virus 
Virus 
Avulaviruses All species excluded with the exception of Newcastle 
disease virus 
Virus 




Bartonella spp. B. bacilliformis and B. quintana excluded Bacteria 





Brucella spp. - Bacteria 




Chlamydia spp. All species excluded with the exception of C. psittaci Bacteria 
Coxiella burnetii - Bacteria 
Cryptosporidium 
spp. 
C. hominis excluded Protozoa 
Ebolavirus - Virus 
Echinococcus spp. - Helminth 
Ehrlichia spp. - Bacteria 
Enteroviruses All species excluded with the exception of Swine 
vesicular disease virus 
Virus 
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Escherichia spp. All species excluded with the exception of Shiga-
toxin producing E. coli 
Bacteria 
Flaviviruses All species excluded with the exception of Japanese 
encephalitis virus (JEV), West Nile virus (WNV), 
and Tick-borne-encephalitis virus.  
Virus 
Francisella spp. All species excluded with the exception of F. 
tularensis 
Bacteria 
Hantavirus - Virus 
Henipaviruses - Virus 
Lassa virus - Virus 
Leishmania spp. L. donovani excluded if detected in India Protozoa 
Leptospira spp. - Bacteria 
Listeria spp. - Bacteria 
Lyssavirus All species excluded with the exception of Rabies 
virus 
Virus 
Marburg virus - Virus 
Mycobacterium All species excluded with the exception of M. bovis 
and M. avis 
Bacteria 
Nairovirus All species excluded with the exception of Crimean-
Congo haemorrhagic fever virus 
Virus 
Orientia1 -  Bacteria 
Orthopox viruses All species excluded with the exception of Cowpox 
virus, Monkeypox virus, and Vaccinia virus 
Virus 
Pasteurella spp. -  Bacteria 
Phleboviruses All species excluded with the exception of Rift 
Valley fever (RVF) virus 
Virus 
Rickettsia spp.2 R. prowazekii excluded Bacteria 
Salmonella spp. All species, subspecies, and serovars excluded with 
the exception of nontyphoidal Salmonella serovars 
Bacteria 






Streptococcus spp. All species excluded with the exception of S. canis, 
S. suis, S. equi, and S. iniae 
Bacteria 
Taenia spp.  Helminth 




Trichinella spp. - Helminth 
Trypanosoma spp. All species excluded with the exception of T. brucei 
rhodesiense and T. cruzi 
Protozoa 
Varicelloviruses All species excluded with the exception of 
Pseudorabies virus 
Virus 
Vesiculoviruses All species excluded with the exception of Vesicular 
Stomatitis virus 
Virus 
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Yersinia spp. All species excluded with the exception of Y. pestis, 
Y. enterocolitica and Y. pseudotuberculosis 
Bacteria 
1 Orientia was covered by search syntax for Rickettsia.  171 
2 For data extraction, data on Rickettsia were classified as Rickettsia (SFGR) or Rickettsia 172 
(TGR) where the data resolution allowed. When details on the species of Rickettsia were not 173 
given, these data were classified as Rickettsia spp.  174 
 175 
Table 2: Inclusion and exclusion criteria for full text review 176 
Outcome Criterion 
Inclusion: • Febrile population (≥ 2 people with a fever, defined as body temperature 
≥ 38·0°C) 
• Diagnosis of one or more zoonotic pathogens from pre-defined reference 
list of eligible aetiological agents (table 1) 
• Diagnostic test criteria:  
i) Culture of the pathogen from sample(s) collected from a febrile person 
ii) Direct detection of the pathogen (e.g., by PCR based techniques) from 
sample(s) collected from a febrile person 
iii) Serological diagnosis of acute infection based on testing of both acute 
and convalescent phase serum samples and demonstration of 
seroconversion 
iv) Diagnosis of acute infection based on detection of pathogen-specific 
antibody or antigens in a single serum sample only for selected 
pathogens, for which widely accepted case definitions deemed 
pathogen-specific antibody or antigen detection sufficiently accurate1  
v) IgM detection in cerebrospinal fluid (CSF) for selected pathogens for 
which widely accepted case definitions include IgM detection in CSF2  
Exclusion: • Failure to meet inclusion criteria described above  
• Lack of study detail e.g., number of people tested for each pathogen 
• Negative diagnostic test results in all patients  
• Study designed to evaluate diagnostic test and/or vaccine performance 
without presenting novel data on number or proportion of patients 
diagnosed with a study pathogen from a previously described population 
of febrile people.  
• Study described as a group of ≥ 2 people principally classified based on 
a shared (100% frequency) aetiological diagnosis. 
• Review 
1The following met study criteria for valid diagnostics for pathogen detection based on single 177 
sera only: Leptospira spp. agglutination titer of ≥ 800 by microscopic agglutination test in 178 
one serum specimen 26; detection of Hantavirus-specific IgM in a serum sample 27; detection 179 
of virus-specific IgM antibodies in serum with confirmatory virus-specific neutralizing 180 
antibodies for Eastern equine encephalitis virus (EEEV), West Nile virus (WNV), Western 181 
equine encephalitis virus (WEEV), and Venezuelan equine encephalitis virus (VEEV) 28; 182 
identification of lyssavirus specific antibody by indirect fluorescent antibody test or complete 183 
rabies virus neutralization at 1:5 dilution in the serum of an unvaccinated person 29; detection 184 
of viral antigens in blood by enzyme-linked immunosorbent assay for Ebola 30,31, Marburg 185 
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31,32, Lassa 31,33, and Crimean-Congo haemorrhagic fever viruses 31; detection of Rift Valley 186 
fever antigens or IgM in blood by enzyme-linked Immunosorbent assay 34; and 187 
2 IgM detection in CSF was considered a valid diagnostic for EEEV, Japanese encephalitis 188 
virus (JEV), rabies virus, WEEV, WNV and VEEV 28,29,35. 189 
 190 
Data extraction and bias assessment 191 
Data extraction was conducted independently by one of two reviewers (JEBH and MC). 192 
Article-level data were extracted on the location (country and WHO regional classification), 193 
36 study period (start and end year of data collection), and eligibility criteria used in the study. 194 
Each population was classified according to the clinical presentation as undifferentiated or 195 
differentiated. Differentiated febrile populations were further classified as: i) febrile 196 
neurologic; ii) febrile haemorrhagic; iii) febrile gastrointestinal; iv) febrile respiratory; v) 197 
specific febrile aetiology suspected; vi) febrile co-morbid group (i.e., malignancy, 198 
immunocompromise).37-39 Data extracted on each population included any demographic 199 
restriction of the study population, the age range of the study participants, whether the 200 
population was described as inpatient or outpatient, urban or rural, and whether data were 201 
collected during a reported disease outbreak or not. To extract data on zoonotic pathogens, 202 
every article was classified to record if the study reported looking for or diagnosing one or 203 
more febrile individuals with any of the zoonotic pathogens included in the study reference 204 
list (table 1), irrespective of the diagnostics used. Additional data were extracted when the 205 
article reported application of a diagnostic approach that met study validity criteria. For each 206 
combination of article and pathogen, details of the valid diagnostic methods used, the type 207 
and number of samples tested, and the number of positive samples were recorded (appendix 208 
table S3, S4). In instances where more than one valid diagnostic method was used in the 209 
same study for a given pathogen (e.g., culture-based and serologic case definitions), data on 210 
the total number of individuals tested and positive for each pathogen using valid methods 211 
were aggregated. Some articles contributed data on more than one pathogen but no data on 212 
participant numbers were extracted for pathogens not identified using diagnostic approaches 213 
that met study inclusion criteria. 214 
 215 
The principal source of potential bias affecting the interpretation of the findings of this study 216 
is the lack of standardization of the febrile populations included in different studies. Criteria 217 
were defined to classify potential bias in study representativeness and prevalence estimate 218 
precision (appendix table S5).40-42 The representativeness bias criterion was designed to 219 
classify the representativeness of the study population, relative to the general population 220 
where the study was conducted. This was based on the description of the febrile population, 221 
the restriction (if any) of the study sample to specific clinical or demographic sub-populations 222 
and the reporting of disease outbreaks at the time of data collection. Each population was 223 
classified as follows: i) populations classified as undifferentiated febrile with no demographic 224 
restriction and no clinical aetiologies excluded were classified as low risk; ii) populations 225 
classified as undifferentiated febrile with demographic restriction and/or reporting exclusion 226 
of specific aetiologies or syndromes were classified as medium risk; iii) differentiated febrile 227 
populations and those from studies reporting disease outbreaks at the time of data collection 228 
were classified as high risk. The second, outcome-level, bias criterion was designed to 229 
classify risk of bias in the estimated precision of the proportion of fevers attributed to each 230 
pathogen. Thresholds used for this criterion are the sample sizes needed to estimate 231 
proportions of 50% and 10% with 95% confidence and 0·05 precision respectively, assuming 232 
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an infinite population size. Each population was classified as follows: i) proportion estimates 233 
based on a sample size of greater than or equal to 385 were classified as low risk; ii) 234 
proportion estimates based on a sample size of greater than 385 but less than 139 were 235 
classified as medium risk; iii) proportion estimates based on a sample size of less than 139 236 
were classified as high risk. 237 
 238 
Additional potential sources of bias included variation in the pathogens tested for, and 239 
variation in the diagnostic approaches applied. For included studies, data on the pathogens 240 
tested for (with any diagnostic approach) were summarized alongside pathogens for which 241 
diagnostic test criteria were met to qualitatively evaluate the biases introduced by only 242 
extracting data on pathogens diagnosed using methods meeting study inclusion criteria.  243 
 244 
Data analysis  245 
Extracted data on the zoonotic pathogens diagnosed using valid methods, number of 246 
individuals tested for each pathogen, and number of individuals positive for each pathogen 247 
were used to estimate the proportion of fevers attributable to each pathogen for each unique 248 
pathogen and study combination. All analyses were conducted in R21 and plots were made 249 
using the package ggplot2.43 250 
 251 
Role of the funding source 252 
The funders of the study had no role in study design, data collection, data analysis, data 253 
interpretation, or writing of the report. The corresponding author had full access to all the 254 
data in the study and had final responsibility for the decision to submit for publication. 255 
 256 
Results 257 
Database searches yielded a total of 16,332 and 10,574 records through Embase and Medline, 258 
respectively, resulting in a total of 17,852 unique records following de-duplication (figure 1). 259 
A total of 4,531 (25·4%) records were excluded during pre-screening, 13,321 (74·6%) 260 
records were screened and 962 (7·2%) of these were retained after title and abstract review. 261 
In total, 718 (74·6%) articles were excluded during full text review and 244 (25·4%) articles 262 
met all study inclusion criteria and were included (figure 1, appendix table S6). 263 
 264 
Articles included in the review yielded data from 53 (48·2%) of the 110 malaria endemic 265 
countries (figure 2). The majority of articles with a single country origin (n=235) reported 266 
data from Africa (83 of 235 articles, 35·3%) or South-East Asia (81 of 235 articles, 34·5%) 267 
(appendix table S7, figure S1). One hundred and six (45·1%) of the 235 articles with a single 268 
country origin were conducted in one of six dominant countries: India (n=31), United 269 
Republic of Tanzania (n=22), Thailand, (n=20), Nepal (n=12), Bangladesh (n=11), and 270 
Nigeria (n=10). The data reported in the review were gathered between 1994 and 2017 271 
inclusive. 272 
 273 
The 244 articles included for data extraction reported looking for and diagnosing 40 and 31 274 
zoonoses, respectively, in these populations (figure 3). The number of included zoonoses was 275 
reduced to 30 after the criteria for diagnostic testing approach were applied. The 244 articles 276 
yielded data that met diagnostic test criteria for 30 zoonoses that included 17 bacterial 277 
pathogens (56·7%), nine viruses (30·0%), three protozoa (10·0%), and one helminth (3·3%). 278 
Leptospira spp., nontyphoidal Salmonella serovars (NTS) and rickettsioses were the most 279 
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frequently reported bacteria, while Japanese encephalitis virus (JEV), Hantavirus, and West 280 
Nile virus (WNV) dominated among reported viruses (figures 3, 4). 281 
 282 
The number of febrile individuals included in each study population ranged from 4 to 13,845, 283 
with a median of 300 (IQR: 120 – 812). In total, 309 records of zoonotic pathogens causing 284 
fever were extracted from the 244 articles. The proportion of fevers attributed to each 285 
pathogen reported ranged from <1·0% to 95·0% (figure 4). The risk of bias classification in 286 
the precision of the proportion of fevers attributed to each zoonosis was 136 (44·0%) of 309 287 
low risk, 79 (25·6%) of 309 medium risk, and 94 (30·4%) of 309 high risk.  288 
 289 
Of the 244 studies, 87 (35·7%) described the clinical setting as inpatient, 36 (14·8%) as 290 
outpatient, 39 (16·0%) as mixed, and 82 (33·6%) gave no clear classification of the clinical 291 
setting. Thirty (12·3%) studies described the study area as urban, 59 (24·2%) as rural, 45 292 
(18·4%) mixed or both, and 110 (45·1%) gave no clear classification of the study area. 293 
Eighteen (7·4%) studies included adult participants, 43 (17·6%) included children, 153 294 
(62·7%) included both adults and children and 30 (12·3%) gave no clear classification of the 295 
ages included. Of the 244 studies, twelve (4·9%) described a demographically restricted 296 
population, 55 (22·5%) reported some exclusions from the population, and 32 (13·1%) 297 
mentioned exclusion of malaria-infected individuals specifically (appendix table S6). Of the 298 
244 studies, 73 (29·9%) reported looking for more than one zoonosis, 43 (17·6%) diagnosing 299 
more than one zoonosis and 37 (15·2%) contributing data on more than one zoonosis. Of the 300 
244 studies, 10 (4·1%) were described as outbreak investigations and 169 (69·3%) 301 
populations were classified as undifferentiated febrile populations. Among the 75 302 
differentiated populations, 36 (48·0%) had specific febrile aetiologies suspected, 17 (22·7%) 303 
were classified as febrile neurological, eight (10·7%) as comorbid populations, eight (10·7%) 304 
as febrile haemorrhagic, five (6·7%) as febrile gastrointestinal and one (1·3%) as febrile 305 
respiratory. The associations between clinical presentation of febrile populations and the 306 
subset of 25 pathogens identified in the differentiated populations are shown in figure 5. The 307 
risk of bias classification in the representativeness of febrile populations was 121 (49·6%,) of 308 
244 low risk, 45 (18·4%,) of 244 medium risk, and 78 (32·0%,) of 244 high risk.  309 
 310 
Discussion 311 
This systematic review reveals diverse zoonoses causing febrile illness within multiple 312 
malaria-endemic countries, often at high prevalence. However, sparse and patchy reporting 313 
suggests that the prevalence of zoonoses is widely under-estimated. Knowledge of probable 314 
infecting pathogen is crucial to inform clinical management of febrile illness and there is a 315 
clear need for further investigation of the zoonotic causes of febrile illness to generate data 316 
relevant to clinicians, epidemiologists, and health policy makers globally. This study should 317 
generate greater awareness of the clinical importance of zoonoses and provide a pragmatic 318 
starting point for actions to better manage these diseases, for example through improved 319 
diagnostic and clinical treatment algorithms. These findings demonstrate the need for 320 
enhanced epidemiological understanding of multiple zoonoses to inform disease prevention. 321 
 322 
This review reveals substantial gaps in the evidence base, including a complete absence of 323 
eligible studies from more than half of the 110 countries included in the review (figure 2). 324 
There are multiple steps and biases in the processes from a patient seeking care with febrile 325 
illness to the publication of an English language scientific paper on the occurrence and 326 
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prevalence of a specific zoonosis that could be included in this review. The underlying 327 
distribution and relative clinical importance of individual pathogens varies, as do patient 328 
healthcare seeking behaviour, clinical, and patient awareness of different pathogens, 329 
diagnostic capacities, and probability of publication. It is therefore not plausible to expect this 330 
review to yield data on all zoonoses in all countries. However, considering the inclusion of 331 
110 countries and construction of searches for 50 pathogens or pathogen groups, the 332 
identification of just 244 eligible studies underscores the profound overall shortage of robust 333 
quantitative data describing the role of any zoonoses as causes of fever in most malaria-334 
endemic countries.  335 
 336 
The geographic variation in the distribution of studies by country (figure 2) and region 337 
(appendix table S7, figure S2) is likely to be strongly influenced by variation in research and 338 
publication effort. There is noticeable geographic segregation for some zoonoses, with NTS 339 
and SFGR reported more frequently in Africa, and Leptospira spp., Orientia tsutsugamushi, 340 
and typhus-group rickettsioses (TGR) reported more frequently in South-East Asia and 341 
Western Pacific regions (appendix figure S2). For viruses, Lassa virus was reported only in 342 
Africa and JEV predominantly in South-East Asia. The distribution of studies cannot be 343 
interpreted as an accurate reflection of the underlying distribution of zoonotic pathogens, 344 
their prevalence or clinical importance. The pathogens that are looked for depend on factors 345 
such as the diagnostic capacity available, existing data, and local assessment of the likely 346 
causes of febrile illness in a specific location. Once pathogens are identified in any location 347 
there will likely be increased clinical, patient, and community awareness of those pathogens, 348 
as well as improved diagnostic capacity to detect them. In this way, dogma about the ‘known’ 349 
important causes of febrile illness in specific locations can arise and contribute to the neglect 350 
of other pathogens. The findings of this review may help indicate potential gaps in what is 351 
looked for and can highlight pathogens and locations where these dogmas should be 352 
questioned. 353 
 354 
The majority of the 30 zoonotic causes of fever contributing data for this review were 355 
bacteria (56·7%). This proportion is greater than expected from the taxonomic distribution of 356 
all zoonotic pathogens, which comprise 30·1% bacteria44 and also contrasts with the 357 
taxonomic distribution of emerging zoonoses, which are dominated by viruses.13 This finding 358 
reinforces the clinical importance of endemic bacterial zoonoses. The comparisons between 359 
the number of articles that looked for, diagnosed, and contributed data for each of 40 360 
zoonoses reveals the range of zoonotic pathogens investigated and indicates the relative 361 
investigative effort used for each pathogen (figure 3). However, the figures for number of 362 
articles where a pathogen was looked for but not identified must be interpreted with caution 363 
given the high probability of reporting bias and how rarely negative results are reported. For 364 
several pathogens, the number and proportion of articles that reported a zoonotic diagnosis 365 
but did not contribute further data for analysis (because the diagnostic approaches described 366 
did not meet study quality criteria) are substantial (figure 3). This demonstrates that for 367 
many, predominantly bacterial pathogens, suboptimal diagnostic tests or imprecise case 368 
definitions are in widespread use, highlighting the challenges of accurately quantifying 369 
disease prevalence and comparing studies.  370 
 371 
Persistent challenges in the diagnosis of febrile patients include limited laboratory capacity, 372 
reliance on demonstration of seroconversion for confirmed diagnosis of many pathogens, 373 
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unsustainable costs associated with more advanced diagnostic technologies, and lack of 374 
simple and affordable tests for the accurate and timely diagnosis of several zoonotic 375 
pathogens. In addition, the delays in patient presentation that are typical in many resource 376 
limited settings, low magnitude bacteraemia at presentation and, presentation of patients 377 
during the immune phase of illness, all limit the sensitivity of culture or PCR-based 378 
diagnostic approaches when available. These challenges necessitate syndromic approaches to 379 
patient management and broad-spectrum treatment. One specific issue relates to tetracycline 380 
use. This study identified rickettsioses and O. tsutsugamushi as common causes of fever. 381 
These would benefit from treatment with tetracyclines, which are not currently included in 382 
the Integrated Management of Adolescent and Adult Illness (IMAI) algorithms for septic 383 
shock and severe respiratory distress without shock.45 In light of the extensive contribution of 384 
tetracycline-responsive infections to fever in malaria-endemic countries, revisions to clinical 385 
guidelines may be warranted to suggest the empirical use of tetracyclines in addition to beta-386 
lactams in scenarios where the infection with tetracycline-responsive pathogens cannot be 387 
excluded. 388 
 389 
The findings of this review show that one or more zoonotic causes of fever are likely to 390 
present a threat to health in all of the countries included in this review. Only a small 391 
proportion of the febrile populations included in the study were defined as demographically 392 
restricted and most were not clinically differentiated. Even zoonoses commonly linked with 393 
specific syndromes (e.g., Crimean-Congo haemorrhagic fever virus and JEV) were diagnosed 394 
in undifferentiated populations and should thus be considered in the differential diagnosis of 395 
undifferentiated febrile illness. Within populations at risk, it is important that aetiologic 396 
studies are followed by epidemiologic risk factor studies to determine whether certain sub-397 
groups are at higher risk for specific zoonotic diseases. Robust febrile illness surveillance 398 
systems help inform local epidemiology and febrile illness management, and are also 399 
essential for detection of disease outbreaks.46 400 
 401 
There are several important limitations to this study. We examined the contribution of 402 
zoonotic pathogens to febrile illness only in malaria-endemic countries and excluded articles 403 
not available in English from our analysis. The restriction of this review to English language 404 
texts will have reduced the probability that studies from French and Spanish speaking 405 
countries were included and may partially account for some gaps, such as the 23 countries in 406 
Africa and 15 in the Americas for which no eligible studies were identified. Studies reporting 407 
all negative test results were excluded. This strategy was motivated by the inevitable 408 
influence of publication bias and challenges of systematically quantifying the non-reporting 409 
of either diagnostic test performance or the non-detection of specific pathogens. Biases in 410 
testing practices for different pathogens in different locations and with different clinical 411 
febrile presentations will influence the pathogens looked for, detected and reported. The 412 
application of diagnostic criteria that are strictly comparable across pathogens is not feasible. 413 
In this study, strict diagnostic criteria were applied, preferentially including diagnostic 414 
approaches with a high specificity, to minimize the influence of false positives within the 415 
analyses. The bias assessments for study representativeness and precision in the estimates of 416 
proportion of fevers attributable to a given pathogen both reveal that the majority of data 417 
points had medium or high risk of one or both types of bias. This emphasizes the need for 418 
cautious and essentially non-quantitative interpretation of the data extracted from these 419 
studies. Many studies with risk of precision bias due to smaller sample size tended to report 420 
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the highest prevalences of disease attribution to a given pathogen (figure 5); and, 421 
interestingly, these studies were often also classified as high risk for representativeness bias. 422 
Figure 5 shows clear variation in risk of representativeness bias across pathogens, potentially 423 
linked to variation in clinical presentation. For example, the majority of data points for 424 
Japanese encephalitis virus and indeed all data points for Leishmania donovanii are 425 
classified as high risk of representativeness bias. This review focused on studies reporting 426 
diagnostic investigation of patient populations that were principally defined by fever and 427 
populations principally defined by a common aetiological diagnosis were excluded (e.g,. 428 
populations defined by presence or suspicion of one or more zoonosis, some of whom were 429 
febrile). This review therefore had an inherently low sensitivity for studies describing disease 430 
outbreaks. This focus explains, for example, the absence of studies describing the 2014-2016 431 
Ebola West Africa outbreak. The design of this review did not allow explicit investigation of 432 
co-infections, either of zoonoses with malaria or of multiple zoonoses. Co-infections are 433 
likely to be an important factor underlying both the distribution and prevalence of some 434 
zoonotic pathogens, including for example nontyphoidal Salmonella serovars.47 Serological 435 
diagnosis of acute infection based on testing of both acute and convalescent phase sera is 436 
central to the confirmed diagnosis of multiple pathogens included in the study. As a 437 
consequence, individuals who die prior to the collection of convalescent samples are unlikely 438 
to contribute data (in the absence of other valid test options) and the proportions of fevers 439 
attributable to pathogens with high probability of acute fatality will be under-estimated. 440 
Furthermore, no validity criteria regarding the timing of sample collection for acute and 441 
convalescent samples were imposed, leading potentially to false negative results (e.g., 442 
seroconversion not detected because of premature convalescent sampling). For these reasons, 443 
our findings are unlikely to capture the full extent of morbidity and mortality attributable to 444 
zoonoses. 445 
 446 
The data compiled in this review demonstrate the need to consider multiple zoonoses among 447 
the potential causes of febrile illnesses in malaria-endemic countries. Different zoonoses are 448 
likely to be important in different settings. Our study provides a starting point for improving 449 
awareness of first the zoonoses that are known to contribute to febrile illness in different 450 
malaria-endemic regions and second the fever-causing zoonoses with widespread distribution 451 
that should be considered in patient evaluation. The demonstration of major data gaps should 452 
encourage a more open-minded approach when considering zoonoses as a potential cause of 453 
febrile illness. Continued efforts are needed to develop multi-pathogen diagnostics, ideally 454 
with formats appropriate for point of care use. To avoid perpetuation of self-fulfilling 455 
prophesies that can arise when only pathogens tested for (and detected) are assumed to be 456 
present, the development and evaluation of such diagnostics should be informed by data 457 
describing the pathogens present in specific settings and also the wider context. Untapped 458 
sources of information on the distribution and occurrence of fever-causing zoonoses almost 459 
certainly exist, particularly in the animal health sector. One Health efforts to share data and 460 
knowledge between animal and human health sectors could help raise clinician awareness of 461 
locally relevant zoonoses, inform history taking, and guide diagnostic and management 462 
decision making. Control of disease in animal populations and prevention of transmission 463 
from animals to humans are likely to be the most effective ways to reduce human disease risk 464 
with many zoonoses, necessitating active engagement with populations at risk to develop 465 
sustainable disease control interventions. There are substantial challenges to clinicians and 466 
epidemiologists in revealing the true impacts of many zoonoses. The enormous global burden 467 
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of febrile illness and scope for improvements in the diagnosis and treatment of zoonotic 468 
pathogens necessitate efforts to overcome these challenges and translate findings into 469 
important public health gains. 470 
  471 
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Figure 1: Flow diagram of records and articles assessed for the review. 627 
Among the 46 articles excluded because the full text was not accessible in English, the 628 
breakdown of languages was as follows: French (13 articles); Spanish (11 articles); Turkish 629 
(9 articles); Mandarin (6 articles); Portuguese (2 articles); Hebrew (2 articles); Arabic (1 630 
article); Danish (1 article) and Russian (1 article). 631 
 632 
Figure 2: Map illustrating the malaria-endemic countries included in the study and number of 633 
articles contributing data for each country (indicated by colour shading).  634 
 635 
Figure 3: Barchart showing the number of articles that looked for, reported diagnosis of and 636 
contributed data for each of 40, 31 and 30 zoonoses respectively.  637 
These data were tabulated for all zoonoses (n=40) and articles included in the review 638 
(n=244). Bar colour indicates pathogen type and shading differentiates studies that i) 639 
contribute data meeting study diagnostic criteria (left hand bar sections with darkest shading, 640 
n=30 pathogens indicated by *), ii) report diagnosis with approaches that do not meet study 641 
diagnostic criteria (central bar sections with lighter shading, n=31 pathogens that comprised 642 
the 30 with extracted data and Escherichia coli), iii) report looking for but not diagnosing a 643 
zoonosis (right hand bar section with lightest shading, n=40 pathogens, also including 644 
Burkholderia spp. Tick borne encephalitis virus, Marburg virus, Rabies virus, Newcastle 645 
Disease virus, Mycobacterium bovis, Francisella tularensis, Ebola virus and 646 
Cryptosporidium parvum).  647 
 648 
Figure 4: Proportion of fevers attributed to each zoonosis.  649 
The plot includes one data point per study and pathogen combination. The different panels 650 
include data from different WHO regions. Point colour indicates the coding for the risk of 651 
bias for the representativeness of the febrile population and point size is proportional to the 652 
number of individuals tested. Points are jittered on the x axis and shaded to visualize 653 
overlapping points. 654 
 655 
Figure 5: Venn diagram illustrating the associations between febrile population clinical 656 
presentation and pathogens identified.  657 
Circles are scaled to the number of pathogens detected in each type of febrile population. 658 
Undifferentiated, shown in green, 23 pathogens (including pathogens also seen in other 659 
populations); febrile neurological, shown in red, four pathogens; febrile gastrointestinal, 660 
shown in blue, two pathogens; febrile respiratory, shown in purple, one pathogen, febrile 661 
haemorrhagic, shown in yellow, seven pathogens. Five pathogens are not represented in the 662 
figure as they were only detected in febrile populations classified as co-morbid (Listeria spp., 663 
Pasteurella spp. and Toxoplasma gondii) or in febrile populations with a specific febrile 664 
aetiology suspected (Leishmania donavani, and Yersinia pestis).  665 
 666 
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